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Duchenne muscular dystrophy (DMD) is an X-linked
recessive disorder resulting from mutations in the gene
that encodes dystrophin (Koenig et al. 1987). Dystrophin
and the dystrophin-associated proteins (DAP) form a
complex that links the actin-based subsarcolemmal
cytoskeleton to the extracellular matrix component
laminin (merosin) (Campbell, 1995). The function of the
dystrophin–DAP complex has not been determined
definitively, but the complex appears to play a role in the
stabilisation of the sarcolemma both in quiescent muscles
and particularly during contractions (Campbell, 1995;
Lynch et al. 2000b). DMD is characterised by progressive
skeletal muscle degeneration (Moser, 1984). The mdx
mouse has a point mutation in the dystrophin gene and a
lack of dystrophin expression in muscle tissues (Bulfield et
al. 1984). Consequently, the mdx mouse has been used in
a wide range of investigations probing the underlying
mechanisms of DMD (Dangain & Vrbova, 1984; Carnwath
& Shotton, 1987; Stedman et al. 1991; Cox et al. 1993; Im
et al. 1996). 
Of the skeletal muscles studied in the mdx mouse
(Anderson et al. 1988; Coulton et al. 1988a,b; Dupont-
Versteegden & McCarter, 1992; Pastoret & Sebille, 1993,
1995), only the diaphragm muscle exhibits extensive and
progressive degeneration, fibrosis and severe functional
deficits comparable to the clinical symptoms observed in
limb muscles of boys with DMD (Stedman et al. 1991;
Dupont-Versteegden & McCarter, 1992; Petrof et al.
1993; Lynch et al. 1997; Coirault et al. 1999). Despite
numerous studies of the structure–function relationships
of the limb muscles of mdx mice, considerable controversy
still exists as to the muscle mass and force development
compared with data on age-matched control C57BL/10
mice (Faulkner et al. 1997; Gillis, 1999). Issues not
addressed adequately are the highly variable muscle
masses, the low values for maximum absolute and specific
force (Po), and on occasion the inappropriate methods used
to normalise force to a specific Po value (Anderson et al.
1988; Coulton et al. 1988a; Quinlan et al. 1992; Pastoret &
Sebille, 1993, 1995; Hayes & Williams, 1998). In addition,
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1. Differences in the effect of age on structure–function relationships of limb muscles of mdx
(dystrophin null) and control mice have not been resolved. We tested the hypotheses that,
compared with limb muscles from age-matched control mice, limb muscles of 6- to 17-month-
old mdx mice are larger but weaker, with lower normalised force and power, whereas those
from 24- to 28-month-old mdx mice are smaller and weaker. 
2. The maximum isometric tetanic force (Po) and power output of limb muscles from 6-, 17-, 24-
and 28-month-old mdx and control mice were measured in vitro at 25 °C and normalised with
respect to cross-sectional area and muscle mass, respectively. 
3. Body mass at 6 and 28 months was not signifcantly different in mdx and control mice, but that
of control mice increased 16 % by 17 months and then declined 32 % by 28 months. The body
masses of mdx mice declined linearly with age with a decrease of 25 % by 28 months. From 6 to
28 months of age, the range in the decline in the masses of EDL and soleus muscles of mdx and
control mice was from 16 to 28 %. The muscle masses of mdx mice ranged from 9 % to 42 %
greater than those of control mice at each of the four ages and, even at 28 months, the masses
of EDL and soleus muscles of mdx mice were 17 % and 22 % greater than control values. 
4. For mdx mice of all ages, muscle hypertrophy was highly effective in the maintenance of control
values for absolute force for both EDL and soleus muscles and for absolute power of soleus
muscles. Throughout their lifespan, muscles of mdx mice displayed significant weakness with
values for specific Po and normalised power ~20 % lower than values for control mice at each
age. For muscles of both strains, normalised force and power decreased ~28 % with age, and
consequently weakness was more severe in muscles of old mdx than in those of old control mice. 
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limited data are available on power output of limb
muscles of mdx mice (Deconinck et al. 1998; Lynch et al.
2000a), arguably the most important physiological
measure of skeletal muscle function. Few studies have
compared mdx and control mice beyond 18 months old
(Pastoret & Sebille, 1993, 1995; Lefaucheur et al. 1995;
Hayes & Williams, 1998) and hence the major issue of the
interaction of ageing and the ongoing dystrophic process
remains unresolved. 
Partridge (1993) noted that the mdx mouse has been
challenged as a model for structure–function studies of
the dystrophic changes in limb muscles because of the
tendency for the mdx mouse ‘to become sturdy and strong
rather than wasted and weak’. In reality, where on the
continuums between ‘sturdy’ and ‘wasted’ and ‘strong’
and ‘weak’ the muscles of mdx mice lie is not clear. The
lack of clarity arises both from the variability in the
published data on the structural and functional
properties of muscles in mdx mice (Faulkner et al. 1997),
and from the qualitative nature of the terms ‘weak’ and
‘strong’ and ‘wasted’ and ‘sturdy’ (Brooks & Faulkner,
1988; Phillips et al. 1991; Partridge, 1993; Pastoret &
Sebille, 1995). The study was designed to measure the
structural and functional properties of limb muscles of
mdx mice at ages before and after deficits in specific force
and normalised power occur for limb muscles of control
mice (Brooks & Faulkner, 1988; Phillips et al. 1991). Our
rationale was that with the progressive nature of the
dystrophic process, major deficits in structure and
function occur earlier in the lifespan of mdx than control
mice. The hypothesis was that, compared with extensor
digitorum longus (EDL) and soleus muscles from age-
matched control mice, EDL and soleus muscles from 6-
and 17-month-old mdx mice are larger but weaker,
whereas those from 24- and 28-month-old mdx mice are
smaller and weaker. A corollary to our primary
hypothesis is that throughout their lifespan, EDL and
soleus muscles of mdx mice demonstrate greater relative
decreases in muscle mass and absolute and normalised
force and power than control mice. 
METHODS
Animal groups
Four age groups of male mdx and control C57BL mice were studied:
~6, ~17, ~24 and ~28 months old. The specific pathogen-free mice
were obtained from Jackson Laboratories (Bar Harbor, ME, USA)
and then housed in barrier-protected facilities of the Unit for
Laboratory Animal Medicine at the University of Michigan. All
experiments were conducted in accordance with the guidelines
outlined in the Guide for the Care and Use of Laboratory Animals
(USPHS, DHHS Publication Number 85-23 (NIH), Revised 1985,
Bethesda, MD, USA).
Contractile properties
For the measurement of contractile properties, the mice were
anaesthetised with sodium pentobarbitone (70 mg kg_1 I.P.) with
supplemental doses administered as necessary to maintain adequate
anaesthesia such that the animals did not respond to tactile stimuli.
EDL and soleus muscles were isolated and removed from the
anaesthetised mdx and control mice. Mice were then given a lethal
overdose of anaesthetic. The sample sizes for EDL and soleus muscles
from mdx and control mice of each of the four age groups are
indicated in Table 1. Contractile properties were measured on EDL
and soleus muscles in vitro using techniques described previously
(Lynch et al. 2000a). Silk suture was tied to each tendon of the
isolated muscle. The muscles were placed in an experimental chamber
filled with mammalian Ringer solution containing (mM): NaCl 137;
NaHCO3 24; glucose 11; KCl 5; CaCl2 2; MgSO4 1; NaH2PO4 1; and
tubocurarine chloride 0.025; adjusted to pH 7.4. The chamber was
perfused continuously with 95 % O2–5 % CO2 and maintained at a
temperature of 25 °C. One end of the muscle was attached to the lever
arm of a position feedback servomotor (model 300H, Aurora
Scientific Inc., Richmond Hill, Ontario, Canada). The other end of
the muscle was tied to a steel hook of a force transducer (model BG-
50, Kulite Semiconductor Products Inc., Leonia, NJ, USA). The
muscles were stimulated by an electric field generated between two
platinum electrodes placed longitudinally on either side of the
muscle. Square wave pulses 0.2 ms in duration were generated by a
stimulator (model S88, Grass Instruments, Quincy, MA, USA) and
amplified (model DC-300A Series II, Crown International Inc.,
Elkhart, IN, USA) to provide a current intensity sufficient to
produce a maximum isometric tetanic contraction (Po). Muscles were
adjusted to the optimum length (Lo) for the development of isometric
twitch force. Optimum fibre length (Lf) was determined by
multiplying the value for Lo for each muscle by a previously
determined fibre length to muscle length ratio of 0.44 for the EDL
and 0.71 for the soleus muscle (Brooks & Faulkner, 1988). A
frequency–force curve was established at frequencies of 10, 30, 50,
80, 100, 120, 150 and 180 Hz for EDL muscles and 10, 20, 30, 50, 80,
100, 120 and 150 Hz for soleus muscles. The absolute Po was
determined from the plateau of the frequency–force relationship. 
Power output was determined during isovelocity shortening ramps
from 105 to 95 % Lf with the muscle maximally activated. Shortening
of the muscle an equal distance either side of Lf was designed to
enhance force development (Lynch et al. 2000a). Initiation of the
isovelocity shortening ramp and stimulation of the muscle occurred
simultaneously. Stimulation was terminated at the end of the
shortening ramp and the muscle was held isometric allowing it to
relax before returning the muscle to resting length. The optimum
velocity of shortening (Vopt) was defined as the velocity that resulted
in the maximum development of power (Brooks & Faulkner, 1991).
An initial velocity was set, based on previous data for Vopt for these
muscles and then adjusted upwards and downwards until maximum
power output was achieved. Maximum power was calculated as the
product of the average force developed during the shortening ramp
and the velocity of shortening. When a maximum power
measurement had been determined, additional isovelocity
shortenings were made from 100 to 90 % Lf. Frequently, a higher
value for maximum power output was achieved employing this
protocol, particularly for muscles from mdx mice. Maximum power
output was determined from whichever of the two protocols gave the
highest value. 
Histological properties
Following the measurement of the contractile properties, the muscles
were removed from the bath and trimmed of their tendons and any
visible connective tissue. The muscles were blotted, weighed on an
analytical balance and then frozen in isopentane cooled in dry ice and
stored at _80 °C for histological analysis. The muscle to body mass
ratio was obtained by dividing muscle mass by body mass. For the
histological analysis, comparisons were made of cross-sections of
muscles from 6- and 24-month-old mice. The 24- rather than the
28-month-old comparison was chosen because for control mice, age-
related deficits in muscle mass and muscle force have not occurred at
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this age (Brooks & Faulkner, 1988). Furthermore, the histological
sections at 24 months permitted comparisons with the data of
Pastoret & Sebille (1995). For each EDL and soleus muscle of 6- and
24-month-old mdx and control mice, six to eight full cross-sections
were fixed in Bouin’s solution, embedded in paraffin, sectioned at
7 µm, and stained with Ehrlich’s haematoxylin and eosin (H&E). A
few hundred fibres were selected from random sections and
planimetered to ensure that our data were comparable to previously
published data on fibre areas (Anderson et al. 1988) or fibre widths
(Tanabe et al. 1986; Coulton et al. 1988b) of EDL and/or soleus
muscles of mdx and control mice. The total fibre cross-sectional areas
(CSA) of the EDL and soleus muscles were determined by dividing
muscle mass by the product of Lf and 1.06 mg mm
_3, the density of
mammalian skeletal muscle. For muscles of mdx and control mice, the
total fibre CSA was divided by the mean CSA of single fibres to
obtain an estimate of the number of fibres per muscle. The values for
maximum force were divided by the total fibre CSA of the whole
muscle to obtain the specific force (expressed in kN m_2). The power
(W) was normalised with respect to muscle mass (expressed in
W kg_1). The terms ‘weak’ or ‘weakness’ are restricted to references
regarding a deficit in the development of specific force per unit of
total fibre cross-sectional area, as used previously to describe the
specific force of 28-month-old C57BL/6 mice (Brooks & Faulkner,
1988; Phillips et al. 1991). 
Statistics
Data are presented in the text as means ± S.E.M. Differences between
the experimental groups were determined by two-way analysis of
variance (ANOVA). The two factors were the strain (mdx or control)
and the age of the mice. When significance was detected, Tukey’s
post hoc comparison was used to assess the difference. Results were
considered significant if P < 0.05 and significant differences
between groups are indicated in the figures (see legends for details). 
RESULTS
Histological sections 
Cross-sections of the EDL and soleus muscles of 6- and 24-
month-old C57BL control mice stained with H&E showed
normal structure, with peripherally located myonuclei
and only a slight increase in interstitial nuclear density
between the two age groups (Fig. 1). In contrast, in the
cross-sections of EDL and soleus muscles of 6- and
24-month-old mdx mice, ~60 % of the fibres had centrally
located nuclei. The presence of mononuclear cells in the
epimysial space of the muscles of the mdx mice is
consistent with that of an inflammatory response due to
ongoing cycles of damage and regeneration (Anderson et
al. 1988, 1998; Coulton et al. 1988; Lefaucheur et al. 1995;
Pastoret & Sebille, 1995). By 24 months of age, the
number of mononuclear cells in the cross-sections of EDL
and soleus muscles of mdx mice had increased
substantially, consistent with the progressive nature of
the dystrophic condition (Anderson et al. 1998). Compared
with sections from EDL and soleus muscles of 6-month-old
mdx mice, sections from both muscles of 24-month-old mdx
mice showed an increase in the number of mononuclear
cells, amount of connective tissue and fibre degeneration.
There were few mononuclear cells in the limb muscles of
control mice at any of the ages studied.
For control and mdx mice, respectively, the mean single
fibre CSAs for EDL muscles were 1290 ± 56 and
1087 ± 73 µm2 and for soleus muscles, 1224 ± 60 and
930 ± 74 µm2. Despite the relatively small sample of
~400 fibres, our values are within the range for EDL and
soleus muscles of mdx and control mice of similar ages
reported by other investigators (Tanabe et al. 1986;
Anderson et al. 1988; Coulton et al. 1988b), although
Anderson et al. (1988) reported higher values, ~2000 µm2,
for soleus muscles of mdx and control mice. Each of these
groups reported the presence of extremely large fibres
and the small atrophic fibres in muscles of mdx mice as
observed in Fig. 1B, D, F and H. For control mice, the
estimate of the number of fibres was ~1500 for EDL
muscles and ~1100 for soleus muscles. These values are in
good agreement with the values of 1600 ± 715 and
940 ± 197, respectively, obtained by Burkholder et al.
(1994) by the same method of dividing total fibre CSA by
single fibre CSA. The numbers of fibres in EDL and soleus
muscles of mdx mice were estimated to be ~2000 and
~1500, respectively, both of which are ~35 % greater
than values for control mice. This observation is
consistent with reports of branching of fibres in the
muscles of mdx mice (Head et al. 1992). We conclude that
where comparisons were possible, the morphological
characteristics of the EDL and soleus muscles of our mdx
and control mice are in good agreement with previous
observations of these muscles. 
Body masses and muscle masses of EDL and soleus
muscles
For control mice, the body masses increased 16 % from 6
to 17 months of age and then decreased 10 % between 17
and 24 months and 32 % by 28 months (Fig. 2). In
contrast to the curvilinear relationship between body
mass and age for the control mice, the body masses of the
mdx mice declined linearly throughout the lifespan, with
the value 25 % lower for 28-month-old mice compared
with 6-month-old mice. Age had a differential effect on
the body masses of mdx and control mice. The result was
at 17 and 24 months of age, the body masses of mdx mice
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Table 1. Sample sizes for numbers of mice, extensor digitorum longus (EDL) and soleus muscles
in each of the four age groups for C57BL control mice and mdx mice
6 months 17 months 24 months 28 months
—————————— ——————————— —————————— ——————————
Mice EDL Soleus Mice EDL Soleus Mice EDL Soleus Mice EDL Soleus
C57 mice 15 15 11 11 12 6 7 7 7 19 19 15
mdx mice 16 16 11 11 16 4 12 16 10 5 10 10
were 30 % lower than those of control mice, whereas for 6-
and 28-month-old mice the body masses of mdx and
control mice were not different. 
The EDL muscle masses of 28- compared with 6-month-
old mice were 28 % smaller for mdx mice and 22 % smaller
for control mice (Fig. 3A). For soleus muscles, the
differences between 28- and 6-month-old mice were 27 %
smaller for the mdx mice and 16 % for the control mice
(Fig. 3B). Despite the smaller body masses of the mdx
mice, particularly at 17 and 24 months, the masses of the
EDL and soleus muscles of the mdx mice were invariably
greater than the comparable muscles in each of the four
age-matched control groups. The greatest relative
hypertrophy for muscles of mdx compared with control
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Figure 2. Body mass of mdx and control C57BL male
mice plotted at 6, 17, 24 and 28 months old
The effect of age (P < 0.001) and the strain of mouse
(P < 0.001) were both significant. The effect of age was
different for mdx compared with control mice with
significant (P < 0.001) interactions. Here and in
subsequent figures symbols and error bars indicate
means ± 1 S.E.M; where no error bars are apparent they
are masked by the symbol. Asterisks indicate significant
differences between data for mdx and control C57 mice
(P < 0.05).
Figure 1. Cross-sections of EDL (A–D)
and soleus (E–H) muscles from 6- (A,
B, E and F) and 24- (C, D, G and H)
month-old mdx and control mice
stained with haematoxylin and eosin
(H&E)
Note in cross-sections of muscles from
mdx mice: (i) the variability in cross-
sectional area of fibres, (ii) the large
number of small atrophic fibres, (iii) the
large number of central myonuclei,
50–70 %, in muscles of mdx mice.
mice was observed at 6 months of age, when EDL muscles
of mdx mice were 28 % larger than those of control mice
and soleus muscles were 42 % larger. Despite the changes
with age in both body and muscle masses, the muscle
mass/body mass remained remarkably stable. From 6 to
28 months of age, EDL muscles of mdx and control mice
maintained values of 0.46 ± 0.01 and 0.32 ± 0.01,
respectively, and soleus muscles values of 0.41 ± 0.01 and
0.29 ± 0.01, respectively. For each muscle, the muscle
mass/body mass of the mdx mice was ~40 % greater than
that of the control mice and the EDL muscles of mdx and
control mice had a ~15 % greater ratio than the soleus
muscles. 
Contractile properties of the EDL muscle
For EDL muscles from mdx and control mice, the values
for absolute Po are presented in Fig. 4. From 6 to
28 months of age, the absolute Po of the EDL muscles of
control mice declined 35 % and those of the mdx mice
37 %. Although the EDL muscles of the mdx mice had
greater masses than the age-matched control groups at
each of the four ages, the absolute Po of the EDL muscles
of the mdx and control mice did not differ. The specific Po
of EDL muscles of mdx and control mice showed no effect
of age through to 24 months of age, but between 24 and
28 months, the specific Po of mdx mice declined 25 % and
that of the control mice 26 % (Fig. 5A). For each of the
three youngest age groups, the specific Po of the EDL
muscles of the mdx mice were 13, 16 and 10 % lower than
values for muscles of control mice, whereas the values for
28 month old mice were not different (Fig. 5A). 
For the EDL muscles of control mice, the loss in absolute
power was 31 % between 17 and 24 months of age and
21 % between 17 and 28 months of age (Fig. 6). The
absolute power of the EDL muscles of the mdx mice
declined continuously throughout the lifespan and by
28 months of age the loss in absolute power was 43 %. For
6- and 24-month-old mice, the absolute power of EDL
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Figure 3. Mass of EDL (A) and soleus (B) muscles
of mdx and control male mice plotted against age
For both EDL and soleus muscles, the effect of age
(P < 0.001) and the strain of mouse (P < 0.001) were
significant. For both muscles the effect of age was
different for mdx compared with control mice;
significant interactions were observed for the EDL
muscles (P < 0.013) and for the soleus muscles
(P < 0.034). Asterisks indicate significant differences
between data for mdx and control C57 mice
(P < 0.05).
Figure 4. Maximum isometric tetanic force (Po) of
EDL and soleus muscles of mdx and control mice
plotted against age
The effect of age was significant (P < 0.001) for each
muscle, but the strain of mouse had no significant
effect for EDL (P < 0.41) or for soleus (P < 0.86)
muscles. No significant interactions were observed for
the EDL muscles (P < 0.15), but the effect of age was
significantly greater (P < 0.031) for soleus muscles of
mdx mice with a significant difference by
24 months old, whereas absolute Po of soleus muscles
of control mice showed no significant decrease with
age. Asterisks indicate significant differences
between data for mdx and control C57 mice
(P < 0.05).
muscles of mdx and control mice did not differ, but for 17-
and 28-month-old mdx mice, the power was 18 and 36 %
lower than the age-matched control value (Fig. 6). For
EDL muscles of both mdx and control mice, normalised
power decreased dramatically after 17 months of age.
The normalised power of EDL muscles of control mice was
24 % lower at 24 than at 17 months and that of mdx mice,
32 % lower at 28 than at 17 months. The normalised
power of EDL muscles of mdx mice ranged from 22 to
41 % lower than that of control mice. The greatest
difference was between 28-month-old mdx and control
mice (Fig. 6). Compared with control mice, at each age
EDL muscles of mdx mice had a greater deficit in
normalised power than in normalised force. Despite this
discrepancy in normalised power, at each age the Vopt was
not different. Consequently, although the greater
impairment in normalised power than force could be
explained by the presence of slower myosin isoforms, as
proposed by Coulton et al. (1988a), the interaction
between force and velocity is complex, particularly in
muscles of mdx mice. 
Contractile properties of the soleus muscle
For the soleus muscles of both the mdx and control mice,
the absolute Po and specific Po declined linearly with age.
From 6 to 28 months of age, the decline in the absolute Po
was 43 % for the mdx mice and 23 % for control mice and
the decline in the specific Po was 27 % for mdx mice and
15 % for control mice (Figs 4 and 5B). As with the EDL
muscle, the greater muscle mass of the soleus muscle of
mdx mice did not translate into a greater absolute Po for
the soleus muscle (Fig. 4). The one exception was the 21 %
higher value for the absolute Po of soleus muscles of
6-month-old mdx compared with control mice. At none of
the other three ages did the absolute Po of soleus muscles
of mdx and control mice differ. At each of the four ages,
the specific Po of the soleus muscles of the mdx mice was
10, 26, 19 and 24 % lower than control mice. 
For the absolute power of soleus muscles, both strains of
mouse demonstrated an age effect, but no effect of the
strain of mouse was observed (Fig. 6). From 6 to
24 months of age, the absolute power of the soleus
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Figure 5. Maximum isometric specific force (Po) of
EDL muscles (A) and soleus muscles (B) plotted
against age
For EDL muscles, the specific Po of both mdx and
control mice decline with age (P < 0.05). Effect of age
was not significacntly different for the two strains
(P < 0.13 for interactions). For soleus muscles, the
specific Po of both mdx and control mice declined with
age (P < 0.05). Effect of age was not signifcantly
different for the two strains (P < 0.64 for
interactions). Asterisks indicate significant
differences between data for mdx and control C57
mice (P < 0.05).
Figure 6. Absolute power output of EDL and
soleus muscles of mdx and control mice plotted
against age
The effect of age was significant (P < 0.001) for both
muscles and the effect of the strain of mouse was
significant for EDL muscles (P < 0.001), but not for
soleus muscles (P < 0.19). Significant interactions
between age and strain were observed for the EDL
(P < 0.028) and soleus (P < 0.02) muscles. Asterisks
indicate significant differences between data for mdx
and control C57 mice (P < 0.05).
muscles of mdx mice decreased 61 % and that of the
control soleus muscles decreased 46 % between 17 and
24 months. For normalised power, effects attributable
to both strain and age were significant (Fig. 7). For
control mice, the normalised power of the soleus muscles
at 24 months was 36 % lower than the normalised power
at 17 months (Fig. 6). As mdx mice aged from 6 to
24 months, the normalised power of the soleus muscles
decreased 52 %. At 6 months of age, the normalised
power of the soleus muscles of mdx and control mice did
not differ. In contrast, at 17, 24 and 28 months of age
the normalised power of mdx mice were 39, 36 and 53 %
lower than age-matched values for the control mice. 
DISCUSSION
Despite the widespread use of the mdx mouse as an
animal model of DMD (Partridge, 1993), most
investigations have focused on single data points on
young mdx mice (for review see Gillis, 1999). Even studies
of multiple age groups have been limited to the first
18 months, or the early adult portion, of the lifespan
(Anderson et al. 1988; Coulton et al. 1988a,b; Dupont-
Versteegden & McCarter, 1992; Wineinger et al. 1998).
Pastoret & Sebille (1995) initiated the first serious
attempt to investigate the time course of
degeneration–regeneration of leg muscles with
histological and immunostaining techniques and
measures of body and muscle mass throughout the
24 month lifespan of the mdx mice. They reported that
only 8 % of their mdx cohort and 70 % of their control
cohort mice survived to 24 months. In a second study
from the same group, no mdx mice survived beyond
23 months of age compared with a 45 % survival rate for
control mice (Lefaucheur et al. 1995). For our mdx and
control C57BL mice 40 and 80 %, respectively, of the
cohort survived to 24 months and 15 and 50 %,
respectively, survived to 28 months. The major
discrepancies in lifespan between the two data sets are
probably attributable to the conventional housing
conditions of the mice of Pastoret & Sebille (1995) and
Lefaucheur et al. (1995), whereas our mice were specific
pathogen free. A lifetime of exposure to a variety of
unknown pathogens in conventional animal housing
facilities appears to shorten the lifespan particularly of
mdx mice (Florini, 1987). 
The body masses of young mice, both mdx and control,
were not affected by the conventional housing conditions.
The body masses of mdx and control mice stabilised
between 4 and 6 months of age, an age at which Coulton
et al. (1988b) noted 17 % greater body mass for mdx than
control mice. In the present study, the body masses of
mdx and control mice are in reasonable agreement with
other published data at 6 months of age. Neither we nor
Pastoret & Sebille (1995) found any difference between
the two strains at this young age. For mice older than
6 months, the conventional compared with the barrier-
facility housing had a dramatic effect on body mass with
the mdx mice more affected than the control mice. By
24 months of age, body mass of control mice decreased
from 39 to 31 g, a 21 % loss, and for mdx mice from 34 to
13 g, a 65 % loss (Pastoret & Sebille, 1995). At 24 months,
the body mass of our mdx mice, 27.3 g, was twofold
greater than that of the mdx mice of Pastoret & Sebille
(1995). Even though specific pathogen free, both mdx and
control mice in our study experienced an ~30 % loss in
body mass by 28 months. The decline in body mass with
age was linear for mdx mice and curvilinear for control
mice. 
Throughout the lifespan of the mdx mouse the dystrophic
process in skeletal muscles involves a continual cycle of
skeletal muscle fibre degeneration and regeneration
(Zacharias & Anderson, 1991; Beilharz et al. 1992;
Grounds & McGeachie, 1992; Lefaucheur et al. 1995;
Pastoret & Sebille; 1995). Pastoret & Sebille (1995)
concluded that for muscles of mdx mice up to 12 months ,
fibre necrosis was compensated for by a ‘vigorous’
regeneration, whereas for muscles of old mdx mice the
necrotic process persisted, but regeneration declined. The
degenerative changes in muscles of 24-month-old mdx
mice were likened to those observed in patients with
DMD (Lefaucheur et al. 1995; Pastoret & Sebille, 1995).
Considerable support for fibre necrosis exists, even in
muscles of young mdx mice (Carnwath & Shotton, 1987;
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Figure 7. Normalised power output of EDL and
soleus muscles of mdx and control mice plotted
against age
The effect of age (P < 0.001) and the strain of mouse
(P < 0.001) were each significant for both muscles.
The interaction between age and strain was not
significant for EDL muscles (P < 0.15) with the
normalised power of EDL muscles of both strains
decreasing after 17 months of age. For soleus muscles
a significant (P < 0.037) interaction between age and
strain was observed. Asterisks indicate significant
differences between data for mdx and control C57
mice (P < 0.05).
Anderson et al. 1988; Coulton et al. 1988b; Zacharias &
Anderson, 1991; Lefaucheur et al. 1995; Pastoret &
Sebille, 1995). In the present study, ‘extensive myopathic
lesions’ as described by Coulton et al. (1988b) or even a
resemblance to pathological changes associated with DMD
(Lefacheur et al. 1995; Pastoret & Sebille, 1995) were not
observed, but histological sections of muscles from
24-month-old mdx mice showed clear disruptions of fibre
morphology. The most compelling observations of the
ongoing degeneration–regeneration cycle in limb muscles
of mdx mice are the high percentage of central nuclei in
fibres, the variability in the shapes and cross-sectional
areas of fibres, and the large number of small atrophic
fibres (Bulfield et al. 1984; Carnwath & Shotton, 1987;
Coulton et al. 1988b; Zacharias & Anderson, 1991;
Pastoret & Sebille, 1995). These phenomena were also
evident in our histological sections of EDL and soleus
muscles from 6-, but particularly 24-, month-old mdx
mice. As observed previously and in the present study,
the processes of degeneration and regeneration produce
no difference in the mean single fibre CSAs of muscles of
mdx and control mice, but a greater distribution of fibre
diameters (Tanabe et al. 1986; Coulton et al. 1988b), or
fibre CSAs (Anderson et al. 1988).
For muscles of young mdx compared with age-matched
control mice, a number of investigators have reported a
hypertrophy of 20–30 % for EDL and soleus muscles
(Coulton et al. 1988b; Dupont-Versteegden & McCarter,
1992; Pastoret & Sebille, 1993, 1995) and 20 % (Quinlan et
al. 1992) to as much a 58 % (Pastoret & Sebille, 1995) for
tibialis anterior (TBA) muscles. In agreement with these
data, EDL and soleus muscle masses of our 6-month-old
mdx mice demonstrated a hypertrophy of 28 and 42 %,
respectively. The limb muscles of the mdx mice appear to
hypertrophy through the hypertrophy of viable fibres
contracting synergistically with muscle fibres damaged
by the dystrophic process. Compensatory hypertrophy is
most commonly observed in response to chronic
impairment or removal of synergistic muscles (Roy et al.
1982) and has not been described previously in response to
sustained damage to fibres within the same muscle. The
unusual nature of the dystrophic damage is that it
extends over the whole lifespan of the mdx mouse
(Pastoret & Sebille, 1995 and the present study) and
consequently provides a consistent stimulus for the
sustained hypertrophy. In contrast, most types of
damage to muscle fibres in control animals are repaired
quickly and consequently the stimulus is transient
(Brooks & Faulkner, 1990). Pastoret & Sebille (1995)
observed a complete reversal of the hypertrophy of the
TBA muscle mass of mdx mice by 24 months old, with the
mass reduced to 50 % of the control value. In contrast, in
the present study, the EDL and soleus muscles of the
28-month-old mdx mice sustained a hypertrophy of 17
and 22 % greater, respectively, than the muscle masses of
control mice. The maintenance of a ~20 % hypertrophy
throughout the lifespan of the mdx mouse is impressive,
particularly in the face of a continuing cycle of
degeneration and regeneration (Coulton et al. 1988b;
Grounds & McGeachie, 1992; Beilharz et al. 1992; Pastoret
& Sebille, 1995).
The muscle hypertrophy was not restricted to only a few
small limb muscles, since eight muscles from the lower
limbs and trunk of dystrophic mice demonstrated a
similar range of generalised hypertrophy (data not
shown). The maintenance of a generalised muscle
hypertrophy in the face of an ongoing cycle of
degeneration and regeneration (Grounds & McGeachie,
1992; Beilharz et al. 1992, Pastoret & Sebille, 1995) is at
considerable metabolic cost to mdx mice (MacLennan &
Edwards, 1990; Even et al. 1994). The muscle
hypertrophy constitutes a possible detriment to the
structure–function relationships of other tissues, since a
generalised muscle hypertrophy coupled with a 30 %
smaller body mass necessitates atrophy of other tissues. 
The concept that the mdx mouse has a ‘tendency to
become sturdy and strong’ (Partridge, 1993) was not
supported by our data on the structure–function
relationships of EDL and soleus muscles of 6-, 17-, 24- and
28-month-old mdx mice compared with age-matched
control mice. Our hypothesis that limb muscles of mdx
mice are larger but weaker, evidenced by a lesser specific
Po and lesser normalised power output than control
muscles, was supported, not only for both EDL and soleus
muscles of young mice, but for each of the four age
groups. The one exception, the EDL muscles of old mdx
mice, that were larger, but with no difference in Po or
specific Po, was something of an anomaly. Despite the
success of the hypertrophy in the maintenance of
absolute Po and power output of the dystrophic muscles, a
significant weakness was evident in both limb muscles.
Throughout the lifespan, the values for specific Po of the
muscles of the mdx mice averaged 25 % less than the age-
matched control values and normalised power output
averaged 33 % less. 
The low values for normalised force and power arise from
the increased amount of non-contractile tissue or tissue
with a decreased capability for force development
present in the dystrophic muscles. The non-contractile
tissue includes connective and fibrotic tissue (Carnwath &
Shotton, 1987; Anderson et al. 1988; Coulton et al.
1988a,b; Lefaucheur et al. 1995; Pastoret & Sebille, 1995),
whereas damaged fibres or regenerating fibres (Zacharias
& Anderson, 1991; Beilharz et al. 1992; Grounds &
McGeachie, 1992; Lefaucheur et al. 1995; Pastoret &
Sebille; 1995) develop less force per unit of cross-sectional
area or less power per unit mass as evidenced by force
deficits after contraction-induced injury to control
muscles (Brooks & Faulkner, 1990). The lack of
dystrophin and concurrent downregulation of the
proteins in the dystrophin associated glycoprotein
G. S. Lynch and others598 J. Physiol. 535.2
complex results in damage to even passive fibres (Straub
et al. 1997) and even more severe damage when fibres
contract (Deconinck et al. 1998; Brooks, 1998; Gillis,
1999). The hypertrophy of viable fibres synergistic to the
damaged fibres in muscles in mdx mice, resulted in a
hypertrophy that ranged from ~10 to ~40 % throughout
the lifespan of the mdx mice. The hypertrophy
constituted a highly successful adaptation to the
continuous damage to muscle fibres. The success of the
muscle hypertrophy was evidenced at each of the four
ages by the lack of any difference between mdx and
control mice in the absolute Po of EDL and soleus muscles
and in the absolute power output of soleus muscles. 
Considerable evidence supports an aggravation of the
dystrophic process in the older mice (Pastoret & Sebille,
1995; present study). Pastoret & Sebille (1995) also
reported greater damage to soleus muscles than EDL
muscles of mdx mice, attributing the greater damage to
the continual activity of the soleus muscle in posture and
locomotion. In the present study, the histological sections
of muscles from 24-month-old mdx mice, particularly
soleus muscles, show greater evidence of degeneration
and regeneration of fibres than observed at 6 months of
age, although the greater damage observed histologically
was not accompanied by a dramatic loss of force or power.
We find some morphological, but no functional, evidence
of any major difference in the amount of damage
incurred by the two muscles. 
As reported by us (Brooks & Faulkner, 1988, 1991) and
many others (Phillips et al. 1991; Holloszy, 1995), age has
a profound effect on the structure and function of
skeletal muscles of control mice with an increasing
atrophy, weakness, fatigue and susceptibility to injury.
The data on EDL and soleus muscles of the control mice in
the present study are in good agreement with the
decreases with age in muscle masses, forces and powers of
these same muscles of control mice reported previously
(Brooks & Faulkner, 1988, 1990, 1991; Phillips et al.
1991). Our hypothesis that EDL and soleus muscles of
28-month-old mdx mice are smaller and weaker than
muscles from 28-month-old control mice was partially
rejected. The limb muscles of the 28-month-old mdx mice
were definitely not smaller! Although the overall
hypothesis was not supported, for most variables the
slopes of the relationship with age were steeper for data
on muscles of mdx than for control mice. Consequently,
the corollary to our primary hypothesis that EDL and
soleus muscles of 28-month-old mdx mice compared with
6-month-old mdx mice demonstrate decreases in muscle
mass and absolute and normalised force and power was
supported. We concur with Lefaucheur et al. (1995) that
old mdx mice offer exciting new perspectives for
investigations of the pathophysiology of DMD and
potential therapies for successful treatment.
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